Related Experiment Videos
[New pharmaceuticals for patients with atherosclerosis are under development. Antioxidants inhibit LDL modification]
Lakartidningen
|September 27, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Can LDL cholesterol be too low? Possible risks of extremely low levels.
Journal of internal medicine·2017
Enhanced production of 24S-hydroxycholesterol is not sufficient to drive liver X receptor target genes in vivo.
Journal of internal medicine·2011
High levels of 15-oxygenated steroids in circulation of patients with multiple sclerosis: fact or fiction?
Journal of lipid research·2010
4beta-hydroxycholesterol as a marker of CYP3A4 inhibition in vivo - effects of itraconazole in man.
International journal of clinical pharmacology and therapeutics·2009
[Rare manifestations of giant cell arteritis].
Lakartidningen·2026
[Neoehrlichiosis in rituximab-treated patients with MS in Sweden].
Lakartidningen·2026
[Postoperative atrial fibrillation after open heart surgery].
Lakartidningen·2026
[Interaction between psychotic patients and AI-driven chatbots].
Lakartidningen·2026
Safety, tolerability and pharmacokinetics of an NMDA receptor subunit 2B-selective negative allosteric modulator, BI 1569912: Results of three partially randomised, placebo-controlled phase I trials.
Journal of psychopharmacology (Oxford, England)·2026
Rapid Identification of Multiple Types of Adulterated Ophiocordyceps sinensis by SEM-EDS Based on Micromorphology and Elemental Analysis.
Microscopy research and technique·2026
Flexible molecular chameleons: structural adaptability and therapeutic applications.
Frontiers in chemistry·2026
Integrated quality and safety evaluation of spray-dried Centella asiatica extract powder for oral ingredient development.
Food science and biotechnology·2026